A Pennsylvania mom is suing the maker of Ozempic and Wegovy claiming she nearly died from taking the prescription drugs and wasn’t properly warned about potentially harrowing side effects. Juanita Gantt said her doctor prescribed the trendy weight-loss drugs because she had a higher risk for diabetes and wanted to shed more than 20 pounds. … Read more
Weight-loss drugs are taking a big bite out of the food business. People taking meds like Ozempic, Mounjaro and Wegovy — originally developed to treat Type 2 diabetes — spend less on groceries and have a healthier assortment in their basket, according to a new study on shopping behaviors by analytics firm Grocery Doppio. This is because … Read more
Pfizer plans to move a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday, after scrapping a twice-daily version of the drug late last year. The new drug is part of the second generation of weight-loss pills under development by companies including Eli Lillyand Novo Nordisk … Read more
Researchers say they have uncovered a link between semaglutide — the active ingredient in Ozempic and Wegovy — and sudden vision loss. The risk of developing nonarteritic anterior ischemic optic neuropathy (NAION) is four times higher for diabetics on semaglutide and seven times higher for people taking the drug to lose weight, according to a new study … Read more
Ozempic and Wegovy users are shedding weight — and reducing their boozing, new research finds. Taking the drugs can halve the risk of being diagnosed with alcohol use disorder (AUD) or relapsing, according to a study from the Case Western Reserve University School of Medicine. “This is very promising news in that we may have a … Read more
NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame. A little over a … Read more
The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, federal regulators said Friday. The Food and Drug Administration approved a label change requested by drugmaker Novo … Read more
It’s worth the weight. A new injectable helps patients burn fat five times faster than Ozempic and Wegovy, according to the stunning results of a new clinical trial. The drug — currently known as VK2735 — was developed by California biotech company Viking Therapeutics, whose share price surged 80% after the trial results were announced … Read more
Counterfeit versions of weight-loss related medications are “detrimental to the field of obesity medicine” and can pose severe risks to patient health, particularly to those who rely on them most, according to medical experts. There is growing concern that the shortage of these popular weight-loss related drugs has created a market for suspected counterfeits. The World Health … Read more
Is it over for Ozempic? A new study shows that, in certain cases, about one in five patients are unable to keep off the weight they lost with help from the drug. A report published on Epic Research found that users of diabetes medications like Ozempic and Wegovy — which exploded in popularity by doubling … Read more
The United States of Weight-Loss Drugs. Drugs designed to treat diabetes have become one of the hottest and most controversial weight-loss crazes. Ozempic and Wegovy, a drug called semaglutide designed for people with Type 2 diabetes, helps the pancreas release the right amount of insulin when blood sugar levels are high. However, both have become widely used … Read more
A large U.S. study found no evidence that taking Novo Nordisk’s Ozempic or Wegovy is tied to an increase in suicidal thoughts, researchers reported on Friday. Both Ozempic for type 2 diabetes and the obesity treatment Wegovy have the same active ingredient, semaglutide. Instead, the analysis of electronic medical record data from more than 1.8 … Read more
Eli Lilly on Thursday launched a website to enable people to directly order from the drugmaker including its weight-loss medicine Zepbound as well as connect people with obesity and other conditions with telehealth companies. The service, called LillyDirect, comes on the back of extraordinary demand seen over the last year for powerful weight-loss drugs such as Novo Nordisk’s Wegovy. … Read more
Drugs designed to treat diabetes have become one of the hottest and most controversial weight loss crazes. But some people who hopped on the Ozempic train are starting to regret it, claiming they’ve gained back more weight than they lost when they stopped taking it. Ozempic and Wegovy, a drug called semaglutide designed for people with … Read more
The obesity drug Wegovy can reduce the risk of severe heart problems by 20%, a pivotal study finds, paving the way for applications far beyond weight loss. “It moves from a kind of therapy that reduces body weight to a therapy that reduces cardiovascular events,” said Dr. Michael Lincoff, the study’s lead author and a heart expert … Read more
Another day, another benefit to taking semaglutide, the popular drug marketed as Ozempic and Wegovy. Originally FDA-approved to treat type 2 diabetes, semaglutide was later sold as Wegovy because of its proven weight-loss benefit. (Ozempic contains a smaller dose of semaglutide than Wegovy.) Earlier this month, Wegovy was also shown to reduce the risk of … Read more
Diabetes and weight loss drug Wegovy could also cut cardiovascular risk – CBS News Watch CBS News The maker of diabetes and weight loss medication Wegovy said a trial found that the drug can also cut the risk of cardiovascular disease by 20%. Be the first to know Get browser notifications for breaking news, live … Read more
Wegovy could be good for more than just weight loss — the once-weekly semaglutide shot has been shown to reduce the risk of heart attack and stroke. The popular obesity medication successfully decreased the risk of major adverse cardiovascular events by 20% while observed over a five-year period, the drug’s manufacturer Novo Nordisk announced on … Read more
Novo Nordisk said on Tuesday a large study had shown its highly effective obesity drug Wegovy also had a clear cardiovascular benefit, boosting the Danish drugmaker’s hopes of moving beyond Wegovy’s image as a lifestyle drug. The late-stage trial showed that patients on Wegovy had a 20% lower incidence of heart attack, stroke or death … Read more
When Eli Diaz lost 22 pounds in three months from taking diabetes drug Wegovy for weight loss, she thought she had found a miracle fix. She felt more confident than ever in form-fitting leggings and sleeveless tops. Diaz, 36, a mom of three who runs a Naples, Florida, construction company with her husband, was desperately … Read more